Costantini S - Search Results

1

Bone aluminum content in predialysis chronic renal failure and its relation with secondary hyperparathyroidism and 1,25(OH)2D3 treatment.

Coen G, Mazzaferro S, Costantini S, Ballanti P, Carrieri MP, Giordano R, Smacchi A, Sardella D, Bonucci E, Taggi F. Coen G, et al. Among authors: costantini s. Miner Electrolyte Metab. 1989;15(5):295-302. Miner Electrolyte Metab. 1989. PMID: 2811788

2

Renal osteodystrophy in predialysis and hemodialysis patients: comparison of histologic patterns and diagnostic predictivity of intact PTH.

Coen G, Ballanti P, Bonucci E, Calabria S, Costantini S, Ferrannini M, Giustini M, Giordano R, Nicolai G, Manni M, Sardella D, Taggi F. Coen G, et al. Among authors: costantini s. Nephron. 2002 May;91(1):103-11. doi: 10.1159/000057611. Nephron. 2002. PMID: 12021526 Clinical Trial.

3

Deferoxamine test and PTH serum levels are useful not to recognize but to exclude aluminum-related bone disease.

Mazzaferro S, Coen G, Ballanti P, Costantini S, Bondatti F, Giordano R, Manni M, Pasquali M, Perruzza I, Sardella D, et al. Mazzaferro S, et al. Among authors: costantini s. Nephron. 1992;61(2):151-7. doi: 10.1159/000186863. Nephron. 1992. PMID: 1630538

4

Treatment with 1,25(QH)2D3 in predialysis chronic renal failure.

Coen G, Mazzaferro S, Ballanti P, Costantini S, Bonucci E, Bondatti F, Manni M, Pasquali M, Sardella D, Taggi F. Coen G, et al. Among authors: costantini s. Contrib Nephrol. 1991;90:183-8. doi: 10.1007/BF00306433. Contrib Nephrol. 1991. PMID: 1959344 No abstract available.

5

Experimental aluminum intoxication and parathormone: effects on the mineralization process.

Ballanti P, Mocetti P, Della Rocca C, Bonucci E, Costantini S, Giordano R, Ioppolo A, Mantovani A. Ballanti P, et al. Among authors: costantini s. Miner Electrolyte Metab. 1989;15(4):233-40. Miner Electrolyte Metab. 1989. PMID: 2761490

6

Aluminum bone content in dialysis osteodystrophy with secondary hyperparathyroidism.

Pizzarelli F, Ballanti P, Costantini S, Mocetti P, Giordano R, Della Rocca C, Fabrizi F, Bonucci E, Maggiore Q. Pizzarelli F, et al. Among authors: costantini s. Miner Electrolyte Metab. 1988;14(2-3):129-34. Miner Electrolyte Metab. 1988. PMID: 3380068

7

Dynamics of bone aluminum over one year of functioning renal graft.

Bertolone G, Andriani M, Bonucci E, Ballanti P, Costantini S, Giordano R, Mattiello G, Calconi G, Maresca MC, Galardi N, et al. Bertolone G, et al. Among authors: costantini s. Nephron. 1993;64(4):540-6. doi: 10.1159/000187397. Nephron. 1993. PMID: 8366978

8

Aluminum removal after chronic intoxication in rats.

Giordano R, Ioppolo A, Ciaralli L, Rubbiani M, Vernillo I, Costantini S. Giordano R, et al. Among authors: costantini s. Res Commun Chem Pathol Pharmacol. 1989 Jan;63(1):119-27. Res Commun Chem Pathol Pharmacol. 1989. PMID: 2916077

9

Diagnostic value of serum peptides of collagen synthesis and degradation in dialysis renal osteodystrophy.

Mazzaferro S, Pasquali M, Ballanti P, Bonucci E, Costantini S, Chicca S, De Meo S, Perruzza I, Sardella D, Taggi F, et al. Mazzaferro S, et al. Among authors: costantini s. Nephrol Dial Transplant. 1995;10(1):52-8. Nephrol Dial Transplant. 1995. PMID: 7724029

10

Relative roles of intestinal absorption and dialysis-fluid-related exposure in the accumulation of aluminium in haemodialysis patients.

Mazzaferro S, Perruzza I, Costantini S, Pasquali M, Onorato L, Sardella D, Giordano R, Ciaralli L, Ballanti P, Bonucci E, Cinotti GA, Coen G. Mazzaferro S, et al. Among authors: costantini s. Nephrol Dial Transplant. 1997 Dec;12(12):2679-82. doi: 10.1093/ndt/12.12.2679. Nephrol Dial Transplant. 1997. PMID: 9430871

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

517 results

Search Page

Filters